BioCentury
ARTICLE | Clinical News

Oxygent perflubron: Phase II delayed

November 13, 2006 8:00 AM UTC

ALLP said the German Ethics Committee rejected an appeal to start a 65-patient Phase II trial to prevent POI resulting from hypoxia during major surgery. In August, the committee voted against the tri...